Literature DB >> 25676527

Sleep disordered breathing and the risk of psoriasis among US women.

Jeffrey M Cohen1, Chandra L Jackson, Tricia Y Li, Shaowei Wu, Abrar A Qureshi.   

Abstract

Sleep disordered breathing [snoring and obstructive sleep apnea-hypopnea syndrome (OSAHS)] is common in the US and has been associated with negative health outcomes. There has been no long-term prospective study on the association between sleep disordered breathing and psoriasis risk. We prospectively evaluated the association between OSAHS and snoring and incident psoriasis and psoriatic arthritis (PsA) in 71,598 women over an 11-year period (1997-2008) in the Nurses' Health Study. Participants received follow-up questionnaires every 2 years and were asked about snoring, diagnosis of OSAHS, and diagnosis of psoriasis and PsA. We studied individuals who reported data on snoring and OSAHS prior to the diagnosis of psoriasis or PsA. We used Cox proportional hazards to calculate age-adjusted and multivariate risk ratios. Over the follow-up period, there were 524 cases of psoriasis. Women with OSAHS were more likely to have a higher BMI, be hypertensive, have cardiovascular disease, and have type 2 diabetes (p < 0.001 for all). The age-adjusted relative risk (RR) of psoriasis among women with OSAHS was 2.19 (95% CI 1.39-3.45), the multivariate RR was 1.93 (95% CI 1.21-3.08). Further adjusting for night shift work, hypertension, cardiovascular disease, and type 2 diabetes, the multivariate RR was 1.91 (95% CI 1.20-3.05). There was no effect modification by BMI (p = 0.52), hypertension (p = 0.34), or snoring (p = 0.91). OSAHS was not associated with an increased risk of PsA. Although women with OSAHS were more likely to be snorers, we did not find a statistically significant relationship between snoring and the risk of confirmed psoriasis. In this study, we found that women with OSAHS had a significantly increased risk of psoriasis.

Entities:  

Mesh:

Year:  2015        PMID: 25676527     DOI: 10.1007/s00403-015-1536-4

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  6 in total

1.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

Authors:  George Martin; Bruce E Strober; Craig L Leonardi; Joel M Gelfand; Andrew Blauvelt; Arthur Kavanaugh; Linda Stein Gold; Brian Berman; Ted Rosen; Eggert Stockfleth
Journal:  J Clin Aesthet Dermatol       Date:  2016-09-01

2.  Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: a large hospital-based case-control study.

Authors:  Evangelia Papadavid; Maria Dalamaga; Katerina Vlami; Dimitra Koumaki; Sotirios Gyftopoulos; Gerasimos Socrates Christodoulatos; Spyridon Papiris; Dimitrios Rigopoulos
Journal:  Sleep Breath       Date:  2017-05-08       Impact factor: 2.816

3.  Psoriasis and Sleep Apnea: A Danish Nationwide Cohort Study.

Authors:  Alexander Egeberg; Usman Khalid; Gunnar Hilmar Gislason; Lotus Mallbris; Lone Skov; Peter Riis Hansen
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

4.  Relationship between vitamin D in obstructive sleep apnea syndrome and psoriasis patients.

Authors:  Hülya Albayrak; Nevin Fazlıoğlu; Bahadır Batar; Mehmet Emin Yanık; Mustafa Oran; Nejat Altıntaş
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.664

Review 5.  Psoriasis and comorbid diseases: Epidemiology.

Authors:  Junko Takeshita; Sungat Grewal; Sinéad M Langan; Nehal N Mehta; Alexis Ogdie; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

6.  Sleep disorders in patients with psoriasis: a cross-sectional study using non-polysomnographical methods.

Authors:  Hikmet Saçmacı; Gülhan Gürel
Journal:  Sleep Breath       Date:  2019-03-11       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.